Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Me, Kimerling"'
Publikováno v:
Europe PubMed Central
Voluntary counseling and confidential testing center (VCCT), Battambang District, Cambodia.To determine newly diagnosed pulmonary tuberculosis (PTB) prevalence and predicting factors, and assess the utility of TB-related symptoms and yield of sputum
Publikováno v:
Europe PubMed Central
Phnom Penh, Cambodia.To determine the burden of active pulmonary tuberculosis among an HIV-infected cohort and the proportion of drug-resistant strains, using active case-finding adapted to a home care setting.Cross-sectional study. Measures include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::88eaf2af189f4db8664447fa2a840fef
http://europepmc.org/abstract/med/12475145
http://europepmc.org/abstract/med/12475145
Publikováno v:
Europe PubMed Central
Retrospective data analysis of human immunodeficiency virus (HIV) infected patients attending an HIV clinic (referral hospital), Cambodia. Chest X-rays (CXRs) were read independently by onsite and offsite physicians.Data on 881 patients were analyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::89a156a2cabbcc8623406818ff1f8a9a
http://europepmc.org/abstract/med/19275795
http://europepmc.org/abstract/med/19275795
Autor:
White RG; TB Modelling Group, Centre for the Mathematical Modelling of Infectious Diseases, and Department of Infectious Disease Epidemiology, TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Charalambous S; Aurum Institute, Johannesburg, School of Public Health, University of Witwatersrand, Johannesburg, Advancing Treatment and Care for TB/HIV, South African Medical Research Council, Johannesburg, South Africa., Cardenas V; Aurum Institute, Washington DC, USA., Hippner P; Aurum Institute, Johannesburg., Sumner T; TB Modelling Group, Centre for the Mathematical Modelling of Infectious Diseases, and Department of Infectious Disease Epidemiology., Bozzani F; TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Mudzengi D; Aurum Institute, Johannesburg., Houben RMGJ; TB Modelling Group, Centre for the Mathematical Modelling of Infectious Diseases, and Department of Infectious Disease Epidemiology, TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Collier D; WhiteOx, Bristol, UK., Kimerling ME; KNCV Tuberculosis Foundation, The Hague, The Netherlands., Vassall A; TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Pillay Y; South African National TB Control Programme, Pretoria, South Africa., Churchyard G; TB Modelling Group, Centre for the Mathematical Modelling of Infectious Diseases, and Department of Infectious Disease Epidemiology, Aurum Institute, Johannesburg, School of Public Health, University of Witwatersrand, Johannesburg, Advancing Treatment and Care for TB/HIV, South African Medical Research Council, Johannesburg, South Africa.
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2018 Jun 01; Vol. 22 (6), pp. 606-613.
Autor:
Pedrazzoli D; TB Modelling Group, TB Centre and Centre for the Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London., Boccia D; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London., Dodd PJ; Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK., Lönnroth K; World Health Organization, Global Tuberculosis Programme, Geneva, Switzerland, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden., Dowdy DW; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Siroka A; World Health Organization, Global Tuberculosis Programme, Geneva, Switzerland., Kimerling ME; KNCV, Tuberculosis Foundation, The Hague, The Netherlands., White RG; TB Modelling Group, TB Centre and Centre for the Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London., Houben RMGJ; TB Modelling Group, TB Centre and Centre for the Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London.
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2017 Sep 01; Vol. 21 (9), pp. 957-964.
Autor:
Houben RMGJ; TB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, UK; Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: rein.houben@lshtm.ac.uk., Menzies NA; Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA., Sumner T; TB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, UK; Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK., Huynh GH; Institute for Disease Modeling, Seattle, WA, USA., Arinaminpathy N; Department of Infectious Disease Epidemiology, Imperial College London, London, UK; Public Health Foundation of India, Delhi NCR, India., Goldhaber-Fiebert JD; Stanford Health Policy, Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA., Lin HH; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan., Wu CY; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan., Mandal S; Public Health Foundation of India, Delhi NCR, India., Pandey S; Public Health Foundation of India, Delhi NCR, India., Suen SC; Management Science and Engineering Dept, Stanford University, Stanford, CA, USA., Bendavid E; Department of Medicine, Stanford University, Stanford, CA, USA., Azman AS; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Dowdy DW; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Bacaër N; IRD, UMMISCO, Bondy, France., Rhines AS; Department of Biology, Stanford University, Stanford, CA, USA; Johnson & Johnson Global Public Health, Raritan, NJ, USA., Feldman MW; Department of Biology, Stanford University, Stanford, CA, USA., Handel A; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, USA., Whalen CC; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, USA., Chang ST; Institute for Disease Modeling, Seattle, WA, USA., Wagner BG; Institute for Disease Modeling, Seattle, WA, USA., Eckhoff PA; Institute for Disease Modeling, Seattle, WA, USA., Trauer JM; The Burnet Institute, Melbourne, Australia; The Victorian Infectious Diseases Service, at the Peter Doherty Institute, Melbourne, Australia; Department of Microbiology and Immunology, the University of Melbourne at the Peter Doherty Institute, Melbourne, Australia., Denholm JT; The Victorian Infectious Diseases Service, at the Peter Doherty Institute, Melbourne, Australia; Department of Microbiology and Immunology, the University of Melbourne at the Peter Doherty Institute, Melbourne, Australia., McBryde ES; The Burnet Institute, Melbourne, Australia; The Victorian Infectious Diseases Service, at the Peter Doherty Institute, Melbourne, Australia; Department of Microbiology and Immunology, the University of Melbourne at the Peter Doherty Institute, Melbourne, Australia., Cohen T; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Salomon JA; Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA., Pretorius C; Avenir Health, Glastonbury, CT, USA., Lalli M; TB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, UK; Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK., Eaton JW; Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Boccia D; Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK., Hosseini M; Strategic Information Department, The Global Fund, Geneva, Switzerland., Gomez GB; Department of Global Health, University of Amsterdam, Amsterdam, Netherlands; Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands., Sahu S; Stop TB Partnership, Geneva, Switzerland., Daniels C; Stop TB Partnership, Geneva, Switzerland., Ditiu L; Stop TB Partnership, Geneva, Switzerland., Chin DP; Bill and Melinda Gates Foundation, China Office, Beijing, China., Wang L; National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Chadha VK; Epidemiology and Research Division, National Tuberculosis Institute, Bangalore, India., Rade K; World Health Organization, Country Office for India, New Delhi, India., Dewan P; The Bill & Melinda Gates Foundation, New Delhi, India., Hippner P; Aurum Institute. Johannesburg, South Africa., Charalambous S; Aurum Institute. Johannesburg, South Africa., Grant AD; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK., Churchyard G; Aurum Institute. Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa., Pillay Y; National Department of Health, Pretoria, South Africa., Mametja LD; National Department of Health, Pretoria, South Africa., Kimerling ME; Bill and Melinda Gates foundation, Seattle, WA, USA (currently KNCV Tuberculosisn Foundation, The Hague, Netherlands)., Vassall A; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK., White RG; TB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, UK; Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK.
Publikováno v:
The Lancet. Global health [Lancet Glob Health] 2016 Nov; Vol. 4 (11), pp. e806-e815. Date of Electronic Publication: 2016 Oct 06.
Autor:
Menzies NA; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA; Center for Health Decision Science, Harvard T H Chan School of Public Health, Boston, MA, USA. Electronic address: nmenzies@hsph.harvard.edu., Gomez GB; Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands; Department of Global Health, Academic Medical Center, University of Amsterdam, Netherlands; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK., Bozzani F; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK., Chatterjee S; Public Health Foundation of India, Delhi NCR, India., Foster N; Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa., Baena IG; Monitoring and Evaluation Unit, Geneva, Switzerland., Laurence YV; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK., Qiang S; School of Health Care Management and Key Laboratory of Health Economics and Policy Research of Ministry of Health, Shandong University, Jinan, China., Siroka A; Global TB Programme, Geneva, Switzerland., Sweeney S; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK., Verguet S; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA., Arinaminpathy N; Public Health Foundation of India, Delhi NCR, India; Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Azman AS; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Bendavid E; Department of Medicine, Stanford University, Stanford, CA, USA., Chang ST; Institute for Disease Modeling, Seattle, WA, USA., Cohen T; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Denholm JT; Victorian Tuberculosis Program at the Peter Doherty Institute, Melbourne, VIC, Australia; Department of Microbiology and Immunology, University of Melbourne, Melbourne, VIC, Australia., Dowdy DW; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Eckhoff PA; Institute for Disease Modeling, Seattle, WA, USA., Goldhaber-Fiebert JD; Stanford Health Policy, Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA., Handel A; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, USA., Huynh GH; Institute for Disease Modeling, Seattle, WA, USA; Synthetic Neurobiology Group, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA., Lalli M; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK., Lin HH; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan., Mandal S; Public Health Foundation of India, Delhi NCR, India., McBryde ES; Victorian Tuberculosis Program at the Peter Doherty Institute, Melbourne, VIC, Australia; Department of Microbiology and Immunology, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia., Pandey S; Public Health Foundation of India, Delhi NCR, India., Salomon JA; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA; Center for Health Decision Science, Harvard T H Chan School of Public Health, Boston, MA, USA., Suen SC; Department of Management Science and Engineering, Stanford University, Stanford, CA, USA., Sumner T; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK., Trauer JM; Victorian Tuberculosis Program at the Peter Doherty Institute, Melbourne, VIC, Australia; Department of Microbiology and Immunology, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia., Wagner BG; Institute for Disease Modeling, Seattle, WA, USA., Whalen CC; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, USA., Wu CY; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan., Boccia D; Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK., Chadha VK; Epidemiology and Research Division, National Tuberculosis Institute, Bangalore, India., Charalambous S; Aurum Institute, Johannesburg, South Africa., Chin DP; Bill & Melinda Gates Foundation, Seattle, WA, USA., Churchyard G; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Aurum Institute, Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa., Daniels C; Stop TB Partnership, Geneva, Switzerland., Dewan P; Bill & Melinda Gates Foundation, New Delhi, India., Ditiu L; Stop TB Partnership, Geneva, Switzerland., Eaton JW; Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Grant AD; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Africa Centre for Population Health, School of Nursing & Public Health, University of KwaZulu-Natal, Durban, South Africa., Hippner P; Aurum Institute, Johannesburg, South Africa., Hosseini M; Strategic Information Department, The Global Fund, Geneva, Switzerland., Mametja D; National Department of Health, Pretoria, South Africa., Pretorius C; Avenir Health, Glastonbury, CT, USA., Pillay Y; National Department of Health, Pretoria, South Africa., Rade K; World Health Organization Country Office for India, New Delhi, India., Sahu S; Stop TB Partnership, Geneva, Switzerland., Wang L; National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Houben RMGJ; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK., Kimerling ME; KNCV Tuberculosis Foundation, The Hague, Netherlands., White RG; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK., Vassall A; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.
Publikováno v:
The Lancet. Global health [Lancet Glob Health] 2016 Nov; Vol. 4 (11), pp. e816-e826. Date of Electronic Publication: 2016 Oct 06.
Autor:
Houben RM; TB Modelling Group, TB Centre, and Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, UK., Dowdy DW; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Vassall A; Department of Global Health and Development, LSHTM, London, UK., Cohen T; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA., Nicol MP; Division of Medical Microbiology and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service, South Africa., Granich RM; Joint United Nations Programme on HIV/AIDS, World Health Organization (WHO), Geneva, Switzerland., Shea JE; Oxford-Emergent Tuberculosis Consortium, Wokingham, UK., Eckhoff P; Intellectual Ventures Laboratory, Bellevue, Washington, USA., Dye C; HIV, TB Malaria and Neglected Tropical Diseases Cluster, WHO, Geneva, Switzerland., Kimerling ME; Bill and Melinda Gates Foundation, Seattle, Washington, USA., White RG; TB Modelling Group, TB Centre, and Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, UK.
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2014 May; Vol. 18 (5), pp. 509-14.
Autor:
Oramasionwu GE; Epidemic Intelligence Service, Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA., Heilig CM, Udomsantisuk N, Kimerling ME, Eng B, Nguyen HD, Thai S, Keo C, McCarthy KD, Varma JK, Cain KP
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2013 Aug; Vol. 17 (8), pp. 1023-8.
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.
Autor:
Wells WA; Global Alliance for TB Drug Development, New York, NY, USA., Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2013 May; Vol. 13 (5), pp. 449-58. Date of Electronic Publication: 2013 Mar 24.